OUIMETTE MIKE (General Counsel) sold 13.2% of their position (7.75K shares) of PLIANT THERAPEUTICS, INC. on the open market
Open‑market sale worth $206.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 4/3/2023ACC: 0001209191-23-022376
Officer· General Counsel
Since Oct 2020
-7.75K
Net shares
Net seller
$206.3K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
7.75K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−4.87K
Price / share
$26.52
Trade value
$129.26K
% of position
8.3%
3/30/2023
58.54K→53.67K
Common Stock
Direct
Shares
−2.68K
Price / share
$26.74
Trade value
$71.58K
% of position
5.0%
4/3/2023
53.67K→50.99K
Common Stock
Direct
Shares
−200.00
Price / share
$27.45
Trade value
$5.49K
% of position
0.4%
4/3/2023
50.99K→50.79K
Total
Net shares
−7.75K
Net value
-$206.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/30/2023 | S · Sale | −4.87K | $26.52 | $129.26K | 8.3% | 58.54K | 53.67K |
| Common Stock Direct | 4/3/2023 | S · Sale | −2.68K | $26.74 | $71.58K | 5.0% | 53.67K | 50.99K |
| Common Stock Direct | 4/3/2023 | S · Sale | −200.00 | $27.45 | $5.49K | 0.4% | 50.99K | 50.79K |
| Total | −7.75K | -$206.33K | ||||||
Derivative Transactions0
No derivative transactions reported